← All Harvard Bioscience INC filings

Harvard Bioscience INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
HBIO
Harvard Bioscience INC
DEF: Harvard Bioscience 2026 Annual Meeting Proxy
Harvard Bioscience schedules its 2026 Annual Meeting of Stockholders for June 2, 2026, to vote on director elections, executive compensation, and equity plan amendments.
NASDAQ
HBIO
Harvard Bioscience INC
DEF: Harvard Bioscience Seeks Reverse Split to Stay on Nasdaq
Harvard Bioscience, Inc. will hold a Special Meeting on March 6, 2026, to seek stockholder approval for a reverse stock split to maintain its Nasdaq listing.
NASDAQ
HBIO
Harvard Bioscience INC
DEFA14A: Harvard Bioscience, Inc. Files Definitive Proxy Statement
Harvard Bioscience, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
HBIO
Harvard Bioscience INC
DEF: Harvard Bioscience Announces 2025 Annual Meeting of Stockholders, Proposes Amended Incentive Plan
Harvard Bioscience will hold its 2025 Annual Meeting of Stockholders virtually on June 2, 2025, to vote on director election, auditor ratification, executive compensation, and an amended incentive plan.
NASDAQ
HBIO
Harvard Bioscience INC
DEFA14A: Harvard Bioscience, Inc. Files Definitive Proxy Statement
Harvard Bioscience, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
HBIO
Harvard Bioscience INC
DEF 14A: Harvard Bioscience Sets Date for 2024 Annual Stockholders Meeting
Harvard Bioscience announces its 2024 Annual Meeting of Stockholders to be held virtually on May 14, 2024, to vote on director election, auditor ratification, executive compensation, and other business.